Health Care & Life Sciences » Biotechnology | HedgePath Pharmaceuticals Inc.

HedgePath Pharmaceuticals Inc.

HedgePath Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.01
Market Cap
$27.04 M
Shares Outstanding
370.45 M
Public Float
77.3 M

Profile

Address
4830 West Kennedy Boulevard
Tampa Florida 33609
United States
Employees -
Website http://www.hedgepathpharma.com
Updated 07/08/2019
HedgePath Pharmaceuticals, Inc. is clinical stage biopharmaceutical company, which discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. It also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.

Financials

View All
Created with Highcharts 5.0.14HedgePath Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.1 8351 8353 9753 9753 9493 9497 0007 0005 1015 1014 5504 55020132014201520162017201802k4k6k8k

E. Brendan Magrab
Chairman
Stefan J. Cross
Director